By Dr. Shweta Agarwal, MBBS, DGO Medically reviewed by Dr. Shweta Agarwal, MBBS, DGO Last updated: June 2026
Information on this page is educational and does not replace a medical consultation. Outcomes depend on individual clinical factors.
Aansh Hospital & IVF Center is a government-registered Level-2 ART clinic (Reg. No. MH/AC/2024/15441/L2/Chandrapur/132), part of a growing chain of fertility centres across Vidarbha and northern Telangana, with our headquarters and in-house embryology lab in Chandrapur. You can verify our government ART registration directly on the National ART & Surrogacy Registry.
Of all the fertility test results that arrive in patients' hands without enough explanation, AMH is the one I see cause the most unnecessary panic. A number on a report — often presented without an age-matched reference range or a qualifier about the assay used — leads women to conclude they have run out of time, or that pregnancy is no longer possible. In most cases, neither is true.
This post explains what AMH actually measures, what it does and does not tell you, how to read a result alongside your age and antral follicle count (AFC), and what a low AMH result means for your fertility options. The Marathi shorthand for this — कमी AMH म्हणजे काय ("what does low AMH mean?") — captures exactly what this page is here to answer.
For the closely related question of how AMH interacts with age in IVF outcomes, the sibling post IVF Success and Age: Realistic Expectations covers that ground in detail.
What is AMH and where does it come from?
AMH — anti-Müllerian hormone — is a glycoprotein hormone produced by granulosa cells in small antral and pre-antral follicles in the ovaries. Unlike most reproductive hormones, its level stays relatively stable throughout the menstrual cycle, which means the blood test can be done on any day of your cycle — a practical advantage over FSH, which must be measured specifically on days two to four.
Because AMH is produced by small growing follicles rather than larger, dominant follicles, its blood level correlates well with the size of the remaining pool of smaller follicles. More small follicles means more AMH-producing cells, and therefore a higher AMH level. Fewer small follicles — as happens naturally with age — means a lower AMH level.
This is the reason AMH has become the most widely used blood marker of ovarian reserve: it gives a reasonably reliable indication of how many eggs remain available. It does not require a specific cycle day, results are consistent between laboratories using the same platform, and it correlates well with the other main reserve marker — antral follicle count (AFC), measured on ultrasound.
What AMH does not measure is equally important. It does not reflect egg quality, chromosomal competence, or the likelihood of conceiving naturally. Those are different questions, answered by different tools.
What is the difference between ovarian reserve and egg quality?
This distinction is the most important concept on this page, and it is the one most frequently blurred in online information about AMH.
Ovarian reserve is the quantity of eggs remaining in the ovaries — the size of the pool available. AMH and AFC both measure reserve. A higher AMH means a larger remaining pool; a lower AMH means a smaller one. Reserve is what determines how many eggs can be retrieved in an IVF stimulation cycle.
Egg quality refers to the chromosomal integrity of individual eggs — specifically, whether a given egg has the correct number of chromosomes (euploid) or an abnormal number (aneuploid). An aneuploid egg, when fertilised, produces an embryo that is unlikely to implant successfully or that may result in early miscarriage.
The critical point: AMH does not measure egg quality. A woman with a low AMH and fewer eggs may have excellent egg quality — particularly if she is young. Her eggs may be chromosomally healthy; she simply has fewer of them available per stimulation cycle. Egg quality is primarily determined by age, not by the size of the ovarian reserve.
This is why the sibling post IVF Success and Age: Realistic Expectations notes explicitly that "AMH measures quantity not quality" — a point that must be understood before interpreting any AMH result.
Can I still get pregnant with low AMH?
Yes — and this is probably the most important sentence on this page.
A low AMH does not mean you cannot conceive naturally, and it does not mean you cannot conceive at all. Research consistently shows that AMH is a poor predictor of natural conception in the general population. Women with low AMH conceive naturally. Women with low AMH have successful IVF cycles.
What low AMH does predict is ovarian response to stimulation: if you proceed with IVF, a low AMH suggests your ovaries may produce fewer eggs per retrieval cycle compared to someone with a higher AMH. That affects how protocols are planned and how many cycles may be needed to accumulate viable embryos — it does not determine whether pregnancy is possible.
The distinction between "predicts poor IVF response" and "predicts inability to conceive" is clinically meaningful. The first is a planning consideration; the second is not what AMH measures.
One important practical implication: if your AMH is low and you are considering IVF at some point in the future, earlier investigation tends to be more useful than waiting. Not because time has run out — but because more eggs are available sooner, and options including egg freezing can be considered while the reserve is higher.
What affects AMH levels?
AMH declines naturally with age — it is the primary driver of AMH variation across the population. From the late twenties onward, AMH levels fall steadily as the follicle pool diminishes.
Several factors beyond age can reduce AMH:
Endometriosis and ovarian surgery. Endometriomas (chocolate cysts) on the ovaries can reduce ovarian reserve, and surgery to remove them — even carefully performed — carries a risk of further reducing AMH by removing or damaging surrounding ovarian tissue. This is a genuine clinical consideration when planning surgery for endometriosis. See the conditions page on endometriosis for more context.
Chemotherapy and radiotherapy. Some cancer treatments are toxic to ovarian follicles and can substantially reduce AMH. Fertility preservation (egg freezing) before treatment is worth discussing with an oncologist and fertility specialist when cancer treatment is planned.
Smoking. Cigarette smoking is associated with accelerated ovarian ageing and a reduction in AMH. Stopping smoking is one of the most evidence-supported steps a woman can take for her ovarian health.
Genetic factors. Some women have a lower AMH than expected for their age due to genetic predisposition — this is sometimes referred to as diminished ovarian reserve (DOR) without an identifiable cause. See the conditions page on low AMH and diminished ovarian reserve for a detailed overview.
One condition that raises AMH deserves specific mention: polycystic ovary syndrome (PCOS). Women with PCOS typically have a high AMH — often several times the age-expected value — because they have a large number of small antral follicles. This does not mean their egg quality is superior; it reflects the characteristic follicle architecture of PCOS. It does mean that in IVF, women with PCOS and high AMH need carefully adjusted stimulation protocols to avoid ovarian hyperstimulation syndrome (OHSS). See the PCOS conditions page for more detail.
What are the general AMH reference ranges?
AMH reference ranges vary depending on which assay platform is used — historically, the Beckman Coulter Gen II assay produced different numerical values from the Elecsys (Roche) automated platform, and other platforms differ again. Any result you are reading must be interpreted with knowledge of which assay was used. This is not a technicality — it can change whether a result appears "normal" or "low."
Because reference ranges shift by age band, assay platform, and laboratory, we do not publish a generic numeric table here — a specific number taken out of that context can be actively misleading. Your result will be interpreted by your clinician against your age, your AFC, and the reference range used by the laboratory that ran your test.
A result described as "low" in the fertility literature varies by assay and by the clinical definition used. A given result in an older woman has a different clinical meaning than the same result in a younger woman, where it might represent a faster-than-expected decline.
The critical caveat: treat any AMH number you read online as a general guide only, not a clinical cutoff. The same numerical result can have different clinical implications depending on your age, AFC, overall clinical picture, and the assay your laboratory used. Always discuss your specific result with a clinician — not with a table.
How is AMH tested, and does it need to be done on a specific cycle day?
The AMH blood test is one of the most practically straightforward fertility investigations available.
Unlike FSH, which fluctuates significantly across the cycle and should be measured on days two to four, AMH is produced continuously by the growing follicle pool and remains relatively stable throughout the cycle. This means the AMH blood test can be done on any day — there is no need to wait for the start of your next period.
The test requires a standard blood draw — typically a few millilitres from a vein in the arm — processed at an accredited laboratory.
AMH is measured as part of a fertility assessment at Aansh, typically alongside AFC on ultrasound and other baseline investigations. The combination of AMH plus AFC gives a more complete picture of ovarian reserve than either marker alone — AFC is a direct count of visible small follicles, while AMH reflects the hormonal output of those follicles. When the two are consistent with each other, the interpretation is more reliable.
If you have already had an AMH result done elsewhere and want to discuss what it means in the context of your full picture, a free second opinion with Dr. Shweta Agarwal is a good starting point.
What does low AMH mean for IVF specifically?
In IVF, AMH is primarily used to predict ovarian response to stimulation — how many eggs are likely to be retrieved in a stimulation cycle — and to guide decisions about stimulation protocol and medication dose.
A low AMH suggests the ovaries are likely to produce fewer eggs per cycle. This matters for IVF planning in several specific ways:
Protocol selection. Women with low AMH typically benefit from higher doses of stimulation medication and sometimes from specific stimulation protocols individualised for poor responders. The aim is to recruit as many of the available follicles as possible while avoiding the opposite problem — a response that is too strong.
Managing expectations for egg numbers. In a cycle where fewer eggs are retrieved, there are statistically fewer embryos to assess, and the probability that any given cycle produces a blastocyst for transfer is lower. This does not mean the cycle will fail — it means the numbers starting the process are smaller. For some women with low AMH, a strategy of accumulating embryos across more than one retrieval cycle before transfer is considered.
Not over-interpreting a single poor response. A cycle that produces fewer eggs than expected is not a verdict on future cycles. Protocol adjustments, timing, and — where appropriate — the addition of adjunct treatments are reviewed and individualised after each cycle.
The critical point to take away: AMH predicts how many eggs may be retrieved. It does not predict whether those eggs are chromosomally healthy (that is primarily age-driven), and it does not predict whether a transfer will succeed. A woman with low AMH who retrieves two or three eggs and produces one chromosomally competent blastocyst has the same potential for a successful transfer as a woman who started the cycle with a higher reserve. IVF with a lower AMH maximises the use of the eggs that are available — it does not make those eggs less viable per se.
For a full overview of the IVF process and what each stage involves, see IVF treatment at Aansh and the first IVF cycle week-by-week timeline.
What should I do if my AMH is low?
The first thing to do is not panic. A low AMH result is clinical information — it is the start of a conversation, not a verdict.
Practical steps that are genuinely useful:
Get a full picture before drawing conclusions. AMH alone is not sufficient for treatment planning. An ultrasound AFC measurement on the same cycle as or shortly after your AMH, combined with your age and clinical history, gives your clinician a much more useful and complete assessment. A number on a lab slip without these is an incomplete picture.
Do not delay unnecessarily. This is not about urgency or panic — it is about pragmatics. If your reserve is lower than expected, acting sooner means more options are available. Egg freezing, for example, is more useful done earlier than later if your reserve is declining.
Consider egg freezing if you are not yet ready for pregnancy. Egg freezing (oocyte cryopreservation) allows eggs to be retrieved now — while the reserve is at its current level — and stored for future use. The eggs are frozen at their current chromosomal quality (primarily determined by your age at freezing). This is worth discussing if you are in your late twenties or thirties and aware that your reserve is lower than expected.
Explore IVF options with a personalised protocol. Low AMH does not preclude IVF. It means the stimulation protocol needs to be carefully individualised. A fertility assessment at Aansh gives Dr. Shweta Agarwal and Aayush Agarwal, our embryologist, the information needed to plan a cycle tailored to your specific reserve and response profile.
Lifestyle steps with some evidence. Stopping smoking, if you smoke, is the single most evidence-supported lifestyle modification for ovarian reserve. Excessive alcohol and very high or very low BMI may also have modest negative effects. Some women with diminished ovarian reserve are advised to consider antioxidant supplementation — CoQ10 is the most commonly discussed — but evidence for direct benefit on AMH or pregnancy rates remains limited and should be discussed individually before starting.
If you have a result and want to discuss what it means for your situation, WhatsApp us or call +91 80056 85160 to arrange a consultation. There is no need to have a referral — you can book directly.